New high‐throughput fully automated BD‐Tau immunoassay
The first high-throughput, fully automated BD-Tau assay provides fast, highly sensitive, precise results on the Beckman Coulter Access 2 and DxI 9000 platforms. It presents high selectivity between individuals without neurodegenerative disease versus AD and FTD subjects.
Authors
- Jeff C. Todtleben
- Laura Mediger
- Mikaela Nichkova‐Doseva
- Kara Curtis
- Miklos Szabo
- Marnie Wallin
- Ben Schlichtmann
Institutions
- Beckman Coulter Foundation (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101595
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00